These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 19478253
1. Drug hypersensitivity syndrome induced by meglumine antimoniate. Jeddi F, Caumes E, Thellier M, Jauréguiberry S, Mazier D, Buffet PA. Am J Trop Med Hyg; 2009 Jun; 80(6):939-40. PubMed ID: 19478253 [Abstract] [Full Text] [Related]
2. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis. Nilforoushzadeh MA, Jaffary F, Ansari N, Siadat AH, Nilforoushan Z, Firouz A. J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655 [Abstract] [Full Text] [Related]
3. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD. Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547 [Abstract] [Full Text] [Related]
4. Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil. Araujo-Melo MH, Meneses AM, Schubach AO, Moreira JS, Conceição-Silva F, Salgueiro MM, Pimentel MI, Araújo-Silva M, Oliveira RV, Carmo CN, Valete-Rosalino CM. J Laryngol Otol; 2010 Oct; 124(10):1056-60. PubMed ID: 20537206 [Abstract] [Full Text] [Related]
5. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis. Córdoba S, Gandolfo Cano M, Aguado M, Huerta-Brogera M, Romero A, Martínez-Morán C, Borbujo J. Allergy; 2012 Dec; 67(12):1609-11. PubMed ID: 23067046 [Abstract] [Full Text] [Related]
6. [N-methyl glucamine antimoniate or Glucantime]. Rapp C, Simon F, Dordain ML. Med Trop (Mars); 2000 Dec; 60(4):342-3. PubMed ID: 11436584 [No Abstract] [Full Text] [Related]
7. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)]. Barthet M, Brunet P, Bernard JC, Dussol B, Rodor F, Jouglard J, Berland Y, Sahel J. Gastroenterol Clin Biol; 1994 Dec; 18(1):90-2. PubMed ID: 8187998 [No Abstract] [Full Text] [Related]
11. Allopurinol in the treatment of American cutaneous leishmaniasis. Martinez S, Marr JJ. N Engl J Med; 1992 Mar 12; 326(11):741-4. PubMed ID: 1738379 [Abstract] [Full Text] [Related]
14. Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis. Llanos-Cuentas A, Echevarria J, Seas C, Chang E, Cruz M, Alvarez E, Rosales E, Campos P, Bryceson A. Am J Trop Med Hyg; 2007 Jun 12; 76(6):1128-31. PubMed ID: 17556623 [Abstract] [Full Text] [Related]
18. Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children. Shahian M, Alborzi A. Med Sci Monit; 2009 Jun 12; 15(6):CR290-3. PubMed ID: 19478699 [Abstract] [Full Text] [Related]
19. [A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use]. Oliveira MC, Amorim RF, Freitas Rde A, Costa Ade L. Rev Soc Bras Med Trop; 2005 Jun 12; 38(3):258-60. PubMed ID: 15895180 [Abstract] [Full Text] [Related]
20. Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World. Zaraa I, Karoui S, Osman AB. J Dermatol; 2012 Feb 12; 39(2):201-3. PubMed ID: 21950659 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]